Topic: MS

Phase III results for siponimod in SPMS

September 28, 2016  

ECTRIMS DAILY REPORT – SATURDAY EDITION

September 17, 2016  

ECTRIMS DAILY REPORT – FRIDAY EDITION

September 16, 2016  

ECTRIMS DAILY REPORT – THURSDAY EDITION

September 15, 2016  

EMD Serono’s LAUNCH program – A model for academia/industry partnerships

September 7, 2016  

EDSS change an unreliable measure of progression

August 17, 2016  

Brain volume loss associated with cognitive decline in MS

July 27, 2016  

Relevance of assessing body weight in MS patients

June 8, 2016  

ECTRIMS 2015

March 9, 2016  

High-efficacy MAbs in MS: an update

November 25, 2015